Clinical Trials for Gliosarcoma

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

NCT ID: NCT05095376

This clinical trial is studying whether adding a chemotherapy drug called lomustine (Gleostine®) to the usual treatment of temozolomide and radiation therapy can help patients with newly diagnosed ...

Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status)

NCT ID: NCT06806228

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

NCT ID: NCT06934889

This clinical trial is studying two new drugs, ABBV-637 and ABBV-155, to see if they are safe and effective treatments for people with glioblastoma or gliosarcoma, which are aggressive types of bra...

A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma

NCT ID: NCT05698524

This clinical trial is studying a new treatment approach for patients with recurrent glioma, a type of brain cancer that includes conditions like glioblastoma and anaplastic astrocytoma. It aims to...

Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma

NCT ID: NCT04555577

This clinical trial is studying a new treatment approach for patients who have been newly diagnosed with aggressive brain tumors called glioblastoma or gliosarcoma. Researchers want to see how well...

Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma

NCT ID: NCT05864534

**Clinical Trial Summary: Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma** This clinical trial is testing a new way to treat glioblastoma, a type of aggressive brain t...

DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma

NCT ID: NCT03115333

This clinical trial is studying a special type of brain imaging called dynamic susceptibility contrast-enhanced magnetic resonance imaging (DSC-MRI) to see how well it can measure blood flow change...

Study of Pembrolizumab and M032 (NSC 733972)

NCT ID: NCT05084430

This clinical trial is studying the combination of two treatments, Pembrolizumab and M032, for patients with certain types of brain tumors such as glioblastoma multiforme, anaplastic astrocytoma, a...

Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue

NCT ID: NCT05756985

This clinical trial is focused on understanding glioblastoma, a type of aggressive brain tumor, by examining tissue collected during surgery. Researchers want to gather samples from different parts...

Natural Progesterone for the Treatment of Recurrent Glioblastoma

NCT ID: NCT05091866

This clinical trial is looking at the use of natural progesterone, a hormone that the body produces, to see if it can help treat patients whose glioblastoma, a type of brain cancer, has come back a...